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Abstract
Background: The molecular determinants of carcinogenesis, tumor progression and patient
prognosis can be deduced from simultaneous comparison of thousands of genes by microarray
analysis. However, the presence of stroma cells in surgically excised carcinoma tissues might
obscure the tumor cell-specific gene expression profiles of these samples. To circumvent this
complication, laser microdissection can be performed to separate tumor epithelium from the
surrounding stroma and healthy tissue. In this report, we compared RNAs isolated from
macrodissected, of which only surrounding healthy tissue had been removed, and microdissected
rectal carcinoma samples by microarray analysis in order to determine the most reliable approach
to detect the expression of tumor cell-derived genes by microarray analysis.
Results: As microdissection yielded low tissue and RNA quantities, extra rounds of mRNA
amplification were necessary to obtain sufficient RNA for microarray experiments. These second
rounds of amplification influenced the gene expression profiles. Moreover, the presence of stroma
cells in macrodissected samples had a minor contribution to the tumor cell gene expression
profiles, which can be explained by the observation that more RNA is extracted from tumor
epithelial cells than from stroma.
Conclusion: These data demonstrate that the more convenient procedure of macrodissection
can be adequately used and yields reliable data regarding the identification of tumor cell-specific
gene expression profiles.
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Microarray technology permits simultaneous analyses of
the expression profiles of thousands of genes. These anal-
yses allow identification of profiles correlating with prog-
nosis and permit tumor classifications [1-3], but can also
be used to identify genes that are involved in several
molecular processes, like carcinogenesis, metastasis and
responses to treatment (reviewed by ref [4]).
To ensure that the expressions of tumor cell-derived genes
are identified by microarray analysis of surgically excised
carcinomas, the samples can be enriched for tumor cells
by removing the surrounding healthy tissue. However,
besides tumor epithelium with infiltrating cells, these
macrodissected samples contain stroma cells as well. Evi-
dently, after RNA isolation of such macrodissected sam-
ples, tumor epithelium-derived RNA cannot be separated
from RNA specific for stroma. Although informative, the
presence of stroma might obscure the tumor cell gene
expressions, thereby preventing accurate data on tumor
cell expression profiles. Because in rectal carcinoma the
percentages of stroma versus tumor epithelium vary
widely among patients, this high variation might compli-
cate comparisons of different tumor samples even more.
To circumvent this problem, microdissection, such as
Laser Microdissection and Pressure Catapulting (LMPC),
can be used to select tumor epithelial cells exclusively.
Although contamination of infiltrating cells will in this
case also be present and important micro environmental
information of the tumor cells will be missed, RNA
extracted from such microdissected samples is expected to
be more specific for tumor epithelial gene expression than
RNA isolated from macrodissected samples. Comparisons
of gene expression profiles of a small number of carci-
noma samples obtained using macrodissection or micro-
dissection, indeed led to the conclusion that stroma cells
disturb the tumor gene expression profiles [5]. However,
it has also been demonstrated that some degradation of
RNA occurs during the lengthy procedure of laser capture
microdissection, resulting in a decreased correlation
between macro- and randomly microdissected samples
[6]. Another disadvantage of microdissection can be the
limited amount of extracted RNA, requiring an extra
amplification round to get sufficient RNA for microarray
experiments. There are several publications addressing the
effect of amplification on gene expression profiles. T7
polymerase-based mRNA amplification is demonstrated
to be reproducible and to maintain the relative abun-
dances of mRNA transcripts, although lower correlation
coefficients are always observed when amplified samples
are compared to non-amplified samples [7-9]. This ampli-
fication effect becomes more serious with less starting
material, which is the case for microdissected samples. In
addition, a second round of amplification does have a fur-
ther effect on reproducibility [10,11].
In this study, we determined the most reliable way to
detect the expression of tumor cell-derived genes by
microarray analysis: macrodissection or microdissection.
Comparing gene expression profiles of macrodissected
and microdissected rectal carcinoma samples in the same
experimental setting allowed evaluation of the effect of a
second round of RNA amplification as well as evaluation
of the presence of varying amounts of stroma. Quantifica-
tion of both effects demonstrated that the second amplifi-
cation round had a high impact on gene expression
profiles. In addition, epithelial tumor cells as compared to
stroma cells had a much higher contribution to gene
expression profiles than is expected from the quantified
surface percentage. We conclude that the obscuring effect
of stroma on the tumor epithelium gene expression pro-
files appears to be minimal and that therefore in clinical
settings the convenient procedure of macrodissection is
the preferable method to examine rectal carcinomas by
microarray analysis.
Results
Gene expression profiles of macrodissected and 
microdissected rectal carcinomas
In the panel of excised rectal carcinoma samples used for
this study, a high variation in surface percentages of tumor
epithelium versus stroma was observed; percentages of
epithelium ranged from 11 to 82% (Table 1). In order to
compare macro- and microdissection of these carcinoma
samples in microarray experiments, RNA was extracted
Table 1: Percentages epithelial tumor surface and used 
amplification scheme
sample % tumor amplification rounds
epithelium macro micro
tumor stroma
1 11 1 2 nd
2 15 1, 2 2 2
3 17 1 2 2*
4 21 1 2 nd
5 35 1, 2 2 nd
6 37 1 2 nd
7 43 1 2 nd
8 50 1, 2 2 2
9 52 1 2 nd
10 59 1, 2 2 nd
11 59 1, 2 2 2
12 61 1 2 nd
13 71 1 2 nd
14 82 1, 2 2 2
* sample not used for microarray experiment because of insufficient 
aRNA after amplification.Page 2 of 10
(page number not for citation purposes)
BMC Genomics 2005, 6:142 http://www.biomedcentral.com/1471-2164/6/142from carcinoma tissue where surrounding healthy tissue
had been removed (macrodissection), as well as from
tumor epithelium isolated by LMPC (microdissection) of
the same carcinoma samples. The microdissection proce-
dure of tumor epithelium resulted on average in 30 ng of
total RNA. Because 1 µg of mRNA is normally required for
microarray experiments, two rounds of mRNA amplifica-
tion were necessary, yielding on average 15 µg aRNA. For
macrodissected samples one round of mRNA amplifica-
tion was sufficient to get an adequate amount of aRNA. To
be able to examine the effect of the second round of
mRNA amplification on the gene expression profiles, sev-
eral macrodissected samples were amplified a second
round as well (Table 1).
All samples were Cy5-labeled and mixed with an equal
amount of Cy3-labeled reference probe, consisting of
equal amounts of RNA of all macrodissected samples.
After hybridization of cDNA arrays, data were normalized
and filtered, resulting in a set of 2358 genes that gave suf-
ficient signal on all arrays. Based on the expression of
these 2358 genes, hierarchical clustering was performed
to group samples according to similarity in gene
expressions, without information of sample identity (Fig-
ure 1). This unsupervised clustering distinguished two
main clusters according to the number of amplification
cycles. Macrodissected samples that were amplified a sec-
ond round were more similar to twice-amplified micro-
dissected samples than to their original once-amplified
samples. To determine the statistical significance of the
effect of the second amplification cycle, Pearson correla-
tion coefficients between once-amplified macrodissected
samples and their corresponding twice-amplified samples
were calculated. The resulting coefficients were low, in
contrast to the coefficients of independently amplified
samples or of duplicate labeling experiments (Table 2),
excluding that such a change in expression profiles was
induced by experimental variation.
Taken together, these findings indicate that, in this exper-
imental setting, expression profiles were hardly preserved
Unsupervised hierarchical clustering of macro- and microdissected rectal carcinoma samplesFig r  1
Unsupervised hierarchical clustering of macro- and microdissected rectal carcinoma samples. Macrodissected samples 
(squares), microdissected tumor epithelium samples (triangles) and microdissected stroma samples (circles) were clustered 
based on average correlation. Open symbols indicate RNA analyzed after one round of amplification and closed symbols indi-
cate two rounds of amplification. Numbers correspond to the carcinoma samples in Table 1.
1 4 2 13 3 10 11 126 5 914 8 7 14 2 10 7 12 1428 11 16 94 5 14 8 11 1310 112 3 5 8
Table 2: Effect of the second round of amplification. Pearson 
correlation coefficients evaluating the effect of the second round 
of amplification on the gene expression profiles. Twice-amplified 
macrodissected samples were compared to the corresponding 
once-amplified macrodissected samples. Correlation of duplicate 
amplification and labeling experiments are presented as well. In 
case of repeated experiments, Pearson correlation coefficients 
were calculated for each experiment and averaged.
Sample Correlation Coefficient p-value
2 0.24 <0.001
5 0.24 <0.001
8 0.00 0.961
10 0.19 <0.001
11 0.17 <0.001
14 0.15 <0.001
labelling 0.95 <0.001
amplification 0.81 <0.001Page 3 of 10
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random primers, and therefore exclude reliable cross-
comparison of once- and twice-amplified samples.
Evaluation of the bias introduced by second round 
amplification
Low correlation coefficients indicate that the overall gene
expression profile was changed. However, such coeffi-
cients do not specify whether the expression of all genes
was slightly changed or whether the expression of a pro-
portion of genes was altered dramatically. To evaluate the
amplification-induced change in more detail, the number
of genes that were significantly preserved by the second
round of amplification, a "conservative set of genes", was
defined by t-tests according to Nygaard et al. [9]. These
calculations indicated that 42% of the genes were on aver-
age not significantly influenced. Calculating a "rejected set
of genes" indicated that for 20% of the genes the expres-
sions were significantly changed, and most of these
rejected genes (70%) were changed at least three-fold.
This suggests that a substantial proportion of the expres-
sion profile was significantly affected by the second round
of amplification with random primers. However, closer
examination of this "rejected gene-set" revealed that for
the majority of the rejected genes, the amplification-
induced change was in the same direction over all tumor
samples, indicating that the bias for these genes could be
constant. Although changed significantly, a constant bias
might not influence the outcome as long as all tested sam-
ples are amplified for the same number of cycles.
To analyze whether the amplification-induced bias was
constant for all carcinoma samples, we determined the
actual variation for the whole set of 2358 genes. This var-
iation between once- and twice-amplified macrodissected
samples is more indicative for the reproducibility of the
amplification effect on the gene expression profiles.
Therefore, the amplification-induced fold-changes of each
gene were calculated for all tumor samples. These values
were then averaged, which allow calculation of a standard
deviation (SD) of the fold-change for each gene (Figure
2). A high SD indicates that the amplification-induced
change of that gene was less reproducible over the differ-
ent samples. For instance, the expression of a given gene
may be induced ten-fold in one sample, while reduced
ten-fold in the next sample. On average, the amplifica-
tion-induced change is zero, suggesting no effect. How-
ever, the variation of this particular gene among samples
is 100-fold, which is too high to be regarded as reproduc-
ible. To determine which variation-range is acceptable, we
used the 95% normal confidence interval, which is
defined by the mean ± 1.96*SD. An interval with a ten-
fold variation-range has an SD of 0.25 on a log10-based
scale, and an interval with a four-fold variation-range has
an SD value of 0.15. Figure 2 demonstrates that several
genes (8%) have a higher SD than 0.25, indicating that for
these genes the amplification resulted in a highly dis-
persed (>ten-fold) expression pattern. When the cut-off
point of the SD was set at 0.15, a range we propose to be
acceptable, it turned out that 39% of all genes had a
higher standard deviation. For this substantial proportion
of genes, we concluded that the amplification effect was
not constant over the different samples.
Larger contribution of tumor epithelium than stroma to 
gene expression profiles
In the unsupervised clustering (Figure 3) all twice-ampli-
fied samples clustered together. In this subgroup the
macrodissected samples clustered closer to microdissected
tumor samples than to stroma samples. This observation
suggested that in general the effect of stroma on gene
expression profiles of macrodissected samples was smaller
than the contribution of tumor epithelium. To determine
the contributions of epithelial tumor cells and of stroma
cells in the gene expression profiles of macrodissected
Variation in amplification-induced fold-change for the con-served and rejected gene-setsFigure 2
Variation in amplification-induced fold-change for the con-
served and rejected gene-sets. Per gene the fold-change 
induced by the second round of amplification over all sam-
ples was averaged (x-axis) and plotted against the standard 
deviation (SD) of the fold-change (y-axis). Statistically con-
served genes (black) and rejected genes (gray) displayed high 
variation in standard deviations. A cut-off value at which the 
95% normal CI lies between 0.5 and 2 times the expression 
value (± 0.3 on log10-scale) corresponds to an SD of 0.15 
(the 95% normal CI lies within 1.96 standard deviations of 
the mean; in this case SD = 0.3/1.96 = 0.15).
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twice-amplified macrodissected samples with their corre-
sponding microdissected tumor and stroma samples
(Table 3). In this analysis, the relationship between the
macrodissected sample and the corresponding tumor and
stroma samples were quantified according to the formula:
gene expressions of macrodissected sample = α*tumor
expressions + β*stroma expressions. The relative contribu-
tion of tumor epithelium can then be calculated by α/
(α+β). In case of carcinoma sample 14, with 18% stroma
and 82% tumor epithelial surface in the macrodissected
section, the relative contributions of stroma and tumor
mRNA were 7% and 93%, respectively. For carcinoma
sample 2, which had only 15% tumor epithelium surface
in the macrodissected section, stroma and tumor mRNAs
contributed equally to the gene expression profile of the
macrodissected sample. These linear regression analyses
demonstrate that the macrodissected gene expression pro-
file depends much more on the tumor epithelium than
would be expected from the percentage of epithelial
tumor surface.
The relatively high contribution of epithelial tumor cells
suggested that more RNA could be extracted from tumor
epithelium than from stroma. Therefore, the yields of
total RNA isolated per volume microdissected tissue were
compared (Figure 3). Although similar volumes of tumor
epithelium and stroma were microdissected, yields of
total RNA of epithelial tumor samples were on average
3.5-fold higher than yields of stroma RNA (p = 0.001).
This difference between tumor epithelium and stroma
increased when the aRNA yields after two rounds of
amplification were compared. On average, the amount of
aRNA generated from microdissected tumor samples was
eight times higher than the aRNA of equal volumes of
stroma samples (p < 0.001). This difference in mRNA
quantities explained the minor contribution of stroma to
the gene expression profiles of macrodissected samples.
Discussion
Surgically resected rectal carcinomas contain epithelial
tumor cells as well as stroma cells. In microarray
Table 3: Involvement of tumor epithelium and stroma. Linear regression was used to quantify the relative contributions of tumor 
epithelium and stroma to the gene expression profile of the macrodissected sample. If, for one gene, s is the amount of RNA measured 
in microdissected stroma, t is the amount measured in microdissected tumor, and r is the amount RNA measured in the 
macrodissected sample, we assume r = αt+βs, where α and β are unknown coefficients. The last column is the relative contribution of 
tumor epithelium, α/(α+β), assuming that the contributions of stroma and tumor together are 100%. Because we are considering a 
sum of contributions on the linear RNA scale, the regression has to be performed on the non-logged data. The values are averaged in 
case of duplicate labeling experiments and standard errors of coefficients α and β are given.
Sample surface % epithelium tumor α (std error) stroma β (std error) relative tumor 
contribution: α/(α+β)
2 15 0.44 (0.01) 0.46 (0.01) 49%
5 35 0.80 (0.01) nd nd
8 50 0.93 (0.01) 0.06 (0.02) 94%
10 59 0.91 (0.01) nd nd
11 59 0.66 (0.01) 0.14 (0.02) 83%
14 82 0.98 (0.02) 0.07 (0.03) 93%
Total RNA and amplified RNA yields of equal volumes of microdissecte tumor epithelium and stromFigure 3
Total RNA and amplified RNA yields of equal volumes of 
microdissected tumor epithelium and stroma. The average 
yield of total RNA (left axis; closed symbols) isolated from 
tumor epithelium (triangles; mean 50 ng/mm2 of 10 µm thick 
sections), was higher than total RNA isolated from stroma 
(circles; mean 14 ng/mm2; p = 0.001). After two rounds of 
amplification, a higher difference was observed between 
yields of RNA (right axis; open symbols) of microdissected 
tumor epithelium (mean 33 µg/mm2) and stroma (mean 4 µg/
mm2; p < 0.0001).Page 5 of 10
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contribute to the gene expression profiles. The influence
of stroma cells might therefore prevent accurate analysis
of gene expressions specific for epithelial tumor cells,
especially when high percentages of stroma are present in
the carcinoma samples. For rectal carcinomas, the
observed high variation in percentages of epithelial tumor
surface might complicate interpretations of microarray
data even more. Therefore, the question arose whether
these samples had to be microdissected to obtain reliable
tumor epithelial gene expression data.
In this study, we compared gene expression profiles of sev-
eral macrodissected rectal carcinoma samples, where only
surrounding healthy tissue was removed, with the same
samples microdissected by LMPC. Both the effect of a sec-
ond amplification round as well as the effect of stroma on
the gene expression profiles was analyzed in order to
determine the best dissection method to detect the expres-
sion of epithelial tumor-derived genes by microarray anal-
ysis. Unsupervised clustering of the gene expression
profiles resulted in two main clusters according to the
number of amplification rounds. This observation indi-
cates that the second round of amplification, needed for
microdissected samples to get sufficient RNA for microar-
ray experiments, affected the overall gene expression
profiles.
The T7 RNA polymerase-based linear amplification proto-
col [12] is one of the most widely used among the availa-
ble amplification techniques. In this procedure, the
amplification reaction consists of transcription via an
oligo(dT)-primer harboring a T7 promoter sequence.
When second amplification rounds were required, as is
the case for microdissected samples, an additional cDNA
synthesis step was performed with second round primers
followed by the T7-based amplification reaction. Because
these second round primers are random primers, tran-
script sizes will decrease. Quality analysis of the amplified
RNA samples demonstrated that indeed the second round
of amplification slightly reduced transcript fragments
(data not shown). This effect was more pronounced for
microdissected samples, probably because of lower
amounts of input RNA for the amplification procedure
and some degradation occurring during the time-consum-
ing process of microdissection [6].
Most studies determined the amplification effect by com-
paring expression ratios of two non-amplified RNA sam-
ples versus the ratios of the same RNAs amplified. These
studies show that the majority of expression differences
were maintained by the amplification procedure although
a slight decrease in correlation coefficients was observed
[13,14], and the intensity levels were not preserved
[7,9,15]. In order to evaluate macro- versus
microdissection, we determined the effect of the for
microdissection required second amplification reaction
on the gene expression profiles by comparing once- and
twice-amplified samples. The low Pearson correlation
coefficients and the calculated significantly "conserved"
and "rejected" gene-sets according to Nygaard et al. [9]
demonstrate that the overall gene expression profile was
changed by the second round of amplification. In this
cross-comparison analysis, the extreme low correlation
coefficients might be the consequence of the above-sug-
gested loss of intensity levels.
Such a cross-comparison analysis of once- and twice-
amplified samples indicates that the gene expression pro-
file is changed by the amplification reaction, but not
whether this change is reproducible for all samples. Other
studies established that amplification-induced changes
are particularly sequence dependent and not abundance
dependent [10,15], suggesting a fairly constant bias.
Therefore, the variation of the amplification-induced
change over the different samples was determined, as this
variation will be indicative for the consistency of the bias.
When we take a standard deviation of 0.15 as an approxi-
mate quantitative criterion (95% normal confidence
interval, allowing a four-fold variation in expressions
induced by amplification), for 39% of the genes the vari-
ation in the gene expression introduced by amplification
was outside this confidence interval. This analysis indi-
cates that for a substantial proportion of the genes, the
amplification-induced change was not constant.
Importantly, such a high variation was observed with sim-
ilar frequencies in the "conserved" and "rejected" gene-
sets. Therefore, although twice-amplified genes might be
called "conserved" based on a t-test, indicating that the
change on average is around zero, the variation over the
different samples will be changed by the amplification,
resulting in more false-negative and false-positive genes.
Since genes extracted from the microarray analysis require
verification by other biochemical experiments, false-posi-
tive genes will be recognized and can be reclassified. Puta-
tive interesting genes that are false negative will be missed
from the analysis.
Since the second round of amplification affected the gene
expression profiles, the use of once-amplified samples is
highly preferred. The fact that for macrodissected samples
one round of amplification suffices to get enough labeled
mRNA, which results in a far more convenient and cost-
effective procedure [16], supports the use of macrodis-
sected samples. Although the first amplification round
might induce some changes in gene expression as well, the
amplification-induced bias is reported to be larger when
the amounts of input material is low [10,17]. The yields of
RNA isolated from microdissected samples were small,Page 6 of 10
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quantity of 1 µg total RNA could be used in the amplifica-
tion reaction. Therefore, the amplification-induced bias is
probably slightly higher for microdissected samples than
for macrodissected samples. Of note, one round of ampli-
fication is demonstrated to be more sensitive to low abun-
dance transcripts than using total RNA [18-20].
A possible disadvantage of macrodissected samples is the
presence of stroma cells that might disturb the epithelial
tumor-specific gene expression profiles. We therefore
evaluated the contribution of stroma in the macrodis-
sected gene expression profiles. In the unsupervised clus-
tering of twice-amplified samples, macrodissected
samples clustered closer to microdissected tumor samples
than to microdissected stroma samples, suggesting that
epithelial tumor cells had a higher contribution to gene
expression profiles than stroma cells. This observation
was confirmed by linear regression analysis, indicating
that the involvement of stroma in macrodissected gene
expression profiles was minor. In the unsupervised clus-
tering, samples 2 and 14 (low en high percentage of tumor
epithelium, respectively) clustered relatively together with
their corresponding microdissected stroma and tumor
sample. Although this observation suggested an associa-
tion between the surface percentage of tumor epithelium
in the macrodissected sample and the degree of clustering
of this sample with the microdissected tumor sample,
such a clear-cut correlation could not be established. The
contribution of stroma to the gene expression profiles was
not strictly related to the surface percentage and was
smaller than expected from the surface percentage of the
stroma. However, for the sample with 15% tumor epithe-
lium the contributions of stroma and tumor were equal,
indicating that this sample contained probably too much
stroma for adequate analysis of tumor-derived genes. For
such samples a further enrichment for tumor epithelium
is necessary and can probably be attained by
macrodissection.
An explanation for our finding that the contribution of
stroma is relatively small is provided by the observation
that the yields of total RNA as well as of amplified mRNA
from stroma samples were much lower than from equal
volumes of tumor tissue. These findings are presumably
due to a higher density of tumor cells and/or more tran-
scription activity in tumor epithelium compared to
stroma. Although these data are obtained by analysis of
rectal carcinoma samples, our conclusions are probably
applicable to other tumor types with a stroma component
as well. The fact that far less mRNA is isolated from stroma
than from epithelium suggests that the contribution of
stroma to the overall gene expression profile will always
be minor with the consequence that macrodissection
might be the preferred method for other carcinoma types
as well. Furthermore, in case it is absolutely necessary to
discard the stroma gene expression, it might be an option
to perform in silico microdissection [21-23]. These compu-
tational approaches have the advantage that
macrodissected samples can be used, thereby leaving out
the biases caused by the required second round of ampli-
fication in case of manual microdissection. However, it is
important to realize that most of the in silico approaches
are based on the assumption that tumor epithelium and
stroma will equally contribute to the overall gene expres-
sion profile. In this study, we demonstrated that the
stroma contribution is much smaller than expected from
the surface area of the rectal carcinoma sample, which
should be included in the in silico analysis.
Although the influence of stroma-derived RNA on the
expression profiles of genes which are expressed by
stroma as well as by tumor epithelium is small, expression
of genes which are specific for stroma cells, might still be
detectable when using macrodissection [24]. This is an
additional advantage of macrodissection, because
increasing evidence supports an important role for the
microenvironment in carcinoma formation and progres-
sion, and therefore these stroma cells might be of great
interest. For instance, expression of some stroma-specific
genes appeared to be correlated with patient prognosis
[2,25]. Fromique et al. [26] showed that signaling
between epithelial tumor cells and fibroblasts influenced
the gene expression pattern of the tumor cells. For rectal
carcinoma it has been demonstrated that apart from the
pathological characteristics of tumor cells the amount and
type of infiltrate is also relevant for the control of cancer
[27]. When tumor epithelium is selected by LMPC, this
stroma-specific information is missed.
Conclusion
Because rectal carcinoma samples contained varying
amounts of stroma versus tumor epithelium, the question
arose whether macrodissection could be used or whether
the samples should be microdissection for gene expres-
sion profiling. Purification of tumor epithelium by laser
microdissection was supposed to give the most reliable
tumor-specific gene expression profiles. However, we
showed that these overall gene expression profiles are
affected by the required second round of mRNA amplifi-
cation with random primers. The contribution of stroma
to gene expression profiles of macrodissected samples was
much smaller than expected on the basis of the quantified
surfaces. And of even more importance, the interference of
stroma cells with the overall gene expression profiles
appeared to be minor. Therefore, we recommend RNA
isolation of clinically resected carcinomas samples that
are only enriched for tumor epithelium by macrodissec-
tion for microarray experiments.Page 7 of 10
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Macrodissection and microdissection of tissue samples
The experimental outline of this study is depicted in Fig-
ure 4. Fresh frozen rectal carcinoma samples were
obtained from 14 different patients who underwent
surgery in either the Leiden University Medical Center or
the Leyenburg Hospital. All samples were macrodissected
in a cryostat at -20°C by removing surrounding healthy
tissue. Of these, two sections of 30 µm were collected for
total RNA extraction. For the microdissection procedure
[28], sections of 10 µm were cut and adhered to polyeth-
ylene-naphtalate (PEN) membrane slides (P.A.L.M.
Microlaser Technologies AG, Bernried, Germany), fol-
lowed by hydration by rinsing the slides in 100%, 75%
and 50% ethanol. The samples were stained with Mayer's
haematoxylin, briefly rinsed in diethylpyrocarbonate
(DEPC)-treated water and dehydrated in graded ethanols.
All slides were finally air-dried and stored dry at -80°C
until microdissection was performed using the PALM®
Micro Beam microscope (P.A.L.M. Microlaser Technolo-
gies AG) for non-contact laser microdissection and pres-
sure catapulting (LMPC). Microdissection of 0.5–1 mm2
tissue took 30 to 120 minutes per sample.
Sections of 5 µm of each macrodissected sample were
stained with classical haematoxylin and eosin staining
and examined by light microscopy to quantify the surface
percentages of tumor epithelium versus stroma. Table 1
gives an overview of the samples used and the quantified
percentages of tumor epithelium.
Total RNA extraction, mRNA amplification and labeling
For macrodissected samples, the sections were homoge-
nized by vortexing with glass beads in RNA-Bee reagent
(Tel-Test Inc., Friendswood, TX). Total RNA was extracted
according to the manufacturer's protocol of RNA-Bee and
purified using the Qiagen RNeasy mini kit with on-col-
umn DNase digestion according to manufacturer's
instructions (Qiagen Sciences, Germantown, MD). For
microdissected tissues, total RNA was isolated using the
Qiagen RNeasy mini kit with on-column DNAse treat-
ment (Qiagen). Quality of total RNAs was assessed with
lab-on-a-chips on the Agilent 2100 Bioanalyzer (Agilent
Technologies, Palo Alto, California). All samples were
shown to be free of DNA contamination and for each
sample the ratio 28S/18S was >1.5.
Amplifications were performed using Ambion's Mes-
sageAmp™ kit and protocol (Ambion Inc., Austin, TX). For
macrodissected samples, of which on average 30 µg total
RNA was isolated, the first amplification round was
started with 1.0 µg total RNA. This first amplification
round of macrodissected samples yielded on average 24
µg amplified mRNA (aRNA). The second round of ampli-
fication, using random second round primers, was started
with 1.0 µg aRNA in case of macrodissected samples. For
microdissected specimens the whole quantity of isolated
total RNA was used (on average 30 ng total RNA) for the
first round of amplification, and all aRNA was used for the
second round of amplification. Yield of aRNA of these
twice-amplified microdissected samples was on average
15 µg aRNA. Quality of each aRNA was checked on lab-
on-a-chip (Agilent Technologies). Quantification of aRNA
was performed by spectrometry at 260 nm wavelength.
Per microarray experiment, 1.0-µg aliquots of aRNA were
labeled with Cy5-dUTPs (Amersham Biosciences, Buck-
inghamshire, UK) by direct incorporation during a reverse
transcriptase reaction using the CyScribe kit, according to
manufacturer's instructions (Amersham Biosciences). The
labeled cDNAs were mixed with equal amounts of Cy3-
dUTP-labeled cDNA from a once-amplified reference
probe, consisting of equal amounts of RNA from all mac-
rodissected samples.
cDNA microarray
The mixture of labeled reference and sample was purified
on YM30 Microcon columns (Millipore Corporation,
Bedford, MA) together with 20 µg human COT-1 DNA
Schematic overview of the strategy used to compare macro-diss ction and microdissectionFigure 4
Schematic overview of the strategy used to compare macro-
dissection and microdissection. All 14 rectal carcinoma sam-
ples are macrodissected or microdissected for tumor 
epithelium, 6 macrodissected samples were in addition ampli-
fied (amp) a second round and of 4 samples the stroma was 
microdissected as well.
rectal carcinoma (14)
macrodissection microdissection
1 x amp (14) tumor epithelium stroma
2 x amp (4)2 x amp (6) 2 x amp (14)Page 8 of 10
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tRNA (Invitrogen) and 20 µg polyadenylic acid (Sigma-
Aldrich, St. Louis, MO) were added. Preheated hybridiza-
tion buffer (25% formamide, 5× SSC, 0.1% SDS) was
added just before hybridization at 42°C o/n in to human
18K cDNA microarrays slides, manufactured at the Cen-
tral Microarray Facility (CMF) of the Netherlands Cancer
Institute. Protocols, GeneID list and information about
arrays are available at the website of the CMF [29].
Data preparation
Of each slide, two images were scanned using the
GeneTAC LSIV laser scanner (Genomic Solutions, Ann
Arbor, MI) at different gain settings, one at which hardly
any of the spots were saturated and one with a higher gain
to obtain data from lowly expressed genes. Spots were
quantified by using GenePix Pro 4.1 software (Axon
Instruments Inc., Union City, CA). For spot selection an
MS-Excel macro was used [30]. Briefly: spots were cor-
rected for local background noise. Per dye, the intensity of
each spot was normalized to the median of all spots on
the array and for each spot, the ratio of the sample to the
reference was calculated. Because arrays were scanned at
two different settings, ratios from high gain-saturated
spots were used from the low gain scans, while lowly
expressed genes were used from the high gain scans.
Genes saturated in both gains were rejected from analysis.
For other spots, the mean of the ratios of the two scans
was calculated. Finally, ratios were log10-transformed.
Because the goal of this study was to analyze the effects of
macro- and microdissection on overall gene expression
profiles and not to select specific genes, only qualified
genes that were present on all 45 arrays (2358 genes) were
selected for further statistical analyses. The data discussed
in this publication have been deposited in NCBIs Gene
Expression Omnibus (GEO) [31] and are accessible
through GEO Series accession number GSE2738.
Array data analysis
Unsupervised clustering of the genes and samples was per-
formed with Spotfire 7.2 software (Spotfire AB, Göteborg,
Sweden) based on hierarchical clustering of average link-
age correlation of the log10-transformed data. Pearson cor-
relation coefficients and linear regression were calculated
with SPSS 11.0 software for Windows (SPSS Inc., Chicago,
IL). The "conservative" and "rejected" gene sets were cal-
culated according to Nygaard et al. [9]. In summary, for
the "conservative set of genes", each gene with a p-value
less than 0.1 in a t-test assuming unequal variances or in
a t-test assuming equal variances was removed. The
"rejected set of genes" are genes which are significantly
changed when two groups of samples are compared in a t-
test according to the Benjamini-Hochberg procedure [32]
with a false discovery rate of 1%.
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